Jennison Associates LLC Mirati Therapeutics, Inc. Transaction History

Jennison Associates LLC

$160 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$75.82 - $150.97 $19.6 Million - $38.9 Million	-257,939 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$132.01 - $190.29 $578,467 - $833,850	-4,382 Reduced 1.67%	257,939 $37.8 Million
Q3 2021 Nov 09, 2021	BUY	$132.13 - $177.45 $11.8 Million - $15.9 Million	89,329 Added 51.64%	262,321 $46.4 Million
Q2 2021 Aug 12, 2021	BUY	$144.0 - $179.73 $12.9 Million - $16.1 Million	89,395 Added 106.94%	172,992 $27.9 Million
Q1 2021 May 11, 2021	BUY	$158.92 - $221.61 $13.3 Million - $18.5 Million	83,597 New	83,597 $14.3 Million
Q3 2020 Nov 04, 2020	SELL	$113.26 - $167.27 $57.1 Million - $84.4 Million	-504,451 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$72.01 - $120.39 $5.65 Million - $9.45 Million	-78,468 Reduced 13.46%	504,451 $57.6 Million
Q1 2020 May 06, 2020	SELL	$69.78 - $116.21 $332,711 - $554,089	-4,768 Reduced 0.81%	582,919 $44.8 Million
Q4 2019 Feb 07, 2020	SELL	$70.76 - $128.86 $9.39 Million - $17.1 Million	-132,714 Reduced 18.42%	587,687 $75.7 Million
Q3 2019 Nov 08, 2019	SELL	$77.91 - $109.6 $19.2 Million - $27.1 Million	-246,930 Reduced 25.53%	720,401 $56.1 Million
Q2 2019 Aug 06, 2019	SELL	$59.49 - $104.71 $13.4 Million - $23.6 Million	-225,348 Reduced 18.89%	967,331 $0
Q1 2019 May 10, 2019	SELL	$43.65 - $78.95 $1.04 Million - $1.88 Million	-23,785 Reduced 1.96%	1,192,679 $87.4 Million
Q4 2018 Feb 06, 2019	BUY	$32.0 - $47.43 $6.97 Million - $10.3 Million	217,960 Added 21.83%	1,216,464 $51.6 Million
Q3 2018 Nov 08, 2018	BUY	$47.1 - $62.7 $18.1 Million - $24.1 Million	383,785 Added 62.43%	998,504 $47 Million
Q2 2018 Aug 02, 2018	BUY	$26.05 - $52.4 $2.25 Million - $4.52 Million	86,323 Added 16.34%	614,719 $30.3 Million
Q1 2018 Apr 20, 2018	BUY	$17.2 - $34.95 $701,708 - $1.43 Million	40,797 Added 8.37%	528,396 $16.2 Million
Q4 2017 Jan 25, 2018	BUY	$12.65 - $19.0 $6.17 Million - $9.26 Million	487,599	487,599 $8.9 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account